Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of inhaled CHF10073 in healthy volunteers, including the effect of itraconazole on C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• CHF10073

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Pulmonary Fibrosis | Phase 1 | Status: COMPLETED